Academic Handbook Course Descriptors and Programme Specifications
BSc (Hons) Applied Biomedical Sciences with Clinical Trials Programme Specification
Last modified on August 22nd, 2024 at 4:16 pm
Awarding Body | Northeastern University – London |
Teaching Institution | Northeastern University London |
Apprenticeship Standard | Clinical Trials Specialist (degree) ST0609 |
Relevant QAA Benchmark Statement | Biomedical Sciences |
QAA Framework for Higher Education Qualification Level | Honours Level 6 |
Final Award | BSc (Hons) Applied Biomedical Sciences with Clinical Trials |
Exit Awards | CertHE Applied Biomedical Sciences with Clinical Trials
DipHE Applied Biomedical Sciences with Clinical Trials |
Programme Code | LBSBSCI-A |
Approved Start Dates | October 2024 |
Language of Instruction | English |
Language of Assessment | English |
Mode of Study | Part-time blended learning; work related learning |
End point assessment | Non-integrated |
End point assessment organisations | TBC |
HECoS Codes | 100343 |
HESA Cost Centre Code | LBIOL4274A Introduction to Clinical Trials – 112 (4.2%)
LBIOL4283A Applied Cell Biology – 112 (4.2%) LBIOL4284A Biochemistry and Molecular Biology – 112 (4.2%) LBUSI4282A The Project Lifecycle – 133 (4.2%) LBIOL4285A Drug Discovery and Development (Including Pharmacology) – 112 (4.2%) LBIOL4286AHuman Physiology and Pathophysiology – 106 (4.2%) LBIOL4276A Regulatory Environment in Clinical Trials – 112 (8.3%) NCHNAP555 IT Project Management -121 (4.2%) LBIOL52110A Infection and Allergy (Including Applied Microbiology) 112 (4.2%) LBIOL52102A Oncology 112 (4.2%) LBIOL52108A Cell and Gene Therapy – 112 (4.2%) LBIOL52109A Industrialisation, Manufacturing and Health Economics – 105 (4.2%) LBIOL52103A Trial Master File and esystems 112 (4.2%) LBIOL52104A Biological Samples 112 (4.2%) LBIOL52105A Statistical Principles Applied to Clinical Trials 112 (4.2%) LBIOL62125A Critical Thinking and Ethics 112 (4.2%) LBIOL62126A Digital Health and Artificial Intelligence 105 (4.2%) LBIOL62127A Frontier Topics in Bioscience 112 (4.2%) LISYS62112A Business and Change Management 133 (4.2%) LBIOL62121A Clinical Trials Research Project 112 (16.7%) |
Programme Overview
The BSc (Hons) Applied Biomedical Sciences with Clinical Trials is a work-related learning programme that integrates academic learning at degree level with on-the-job practical training to provide a holistic programme of education and training to meet the bioscience skills needs of employers now and in the future. The programme adheres to the Level 6 Clinical Trials Specialist (ST0609) apprenticeship standards.
Learners may study the programme as an apprenticeship or non-apprenticeship. The programme is identical for both streams, only differing in that the apprenticeship stream will receive an additional apprenticeship completion certificate. For both streams, the learner must be in employment, or be sponsored by an employer, with duties aligned to the level 6 Clinical Trials Specialist apprenticeship standard. Learners whose job role aligns to the level 6 Clinical Trials (degree) apprenticeship will study for a full Bachelor’s degree (Stage 1 – 3).
This work-related learning programme will develop professional practice, contextualised in the workplace using industry standard approaches and technologies that are shaped by modern organisations. Learners studying on this programme are employed, or sponsored by an Employer.
The learner will study with Northeastern University London (University) for approximately 60 days a year (or Stage) – i.e. one day per week for 42 weeks each year, and up to three five-day ‘bootcamps’ in any given year; for the duration of the three-year programme.
Additionally, the learner and employer will commit to a further two days per week, for 42 weeks each year, for University-guided work-related training. Learners will study 120 credits per year and will be considered part-time learners by the University. Each course, typically 15 credits, is assessed by a range of activities aligned to industry norms, i.e. almost all assessments relate to workplace activities that are expected in a bioscience-related occupation. The content, and consequently the learning outcomes and methods of assessment, vary between courses. Where possible, assessments will be undertaken in the workplace.
The programme begins with a Welcome Week (non-credit bearing) to the programme covering essential study skills and fostering collegiality. The first course is ‘Introduction to Clinical Trials’, acquainting the learners with the lifecycle and types of clinical trials, followed by ‘Applied Cell Biology’, which looks at the structure and function of eukaryotic and prokaryotic cells. Next, the programme introduces ‘Biochemistry and Molecular Biology’ and ‘Drug Discovery and Development (Including Pharmacology)’. ‘Human Physiology and Pathophysiology’ explores the normal functions and mechanisms of the human organism. ‘The Project Lifecycle’ examines the roles of the project manager and management tools and techniques. Year one, or Stage one, concludes with a 30-credit, eight week course called ‘The Regulatory Environment in Clinical Trials’ where learners will gain hands-on experience on informed consent and the protection of clinical trials participants and will develop their communication skills. This course includes an intensive week of teaching in person.
Year two, or Stage two, starts by introducing the project management lifecycle in ‘IT Project Management’ before examining processes of infection and the human immune response in ‘Infection and Allergy (Including Microbiology)’. This is followed by ‘Oncology’ and advances in ‘Cell and Gene Therapy’. Learners examine demand and supply in the healthcare system and the healthcare markets in ‘Industrialisation, Manufacturing and Health Economics’. Then they study how raw data is collected, stored, cleansed and interrogated in ‘Trial Master File and esystems’. Proceeding with ‘Biological Samples’ which reviews the types and the management of biological samples. Year two, or Stage two finishes with ‘Statistical Principles Applied to Clinical Trials’ is an intensive two-week bootcamp where learners will gain insight into the principles of statistics and how they help to make decisions on the outcome of clinical trials.
Year three, or Stage three starts with reflective practice in ‘Critical Thinking and Ethics’. Learners examine advances in digital science in ‘Digital Health and AI’, followed by ‘Frontier Topics in Bioscience’, taught through the lens of global case study analysis. ‘Business and Change Management’ examines digital transformation and change. Year three, or Stage three culminates with an extensive 24-week clinical trials research project.
Dedicated Success Managers will undertake regular tripartite reviews with learners and their employers (every eight weeks or less) and provide supplementary support for apprentices.
Structure and Requirements
The degree requires that students take courses to the value of 360 credits across three years.
Stage 1 (Level 4)
Required Courses
Welcome Week
LBIOL4274A Introduction to Clinical Trials (15 credits)
LBIOL4283A Applied Cell Biology (15 credits)
LBIOL4284A Biochemistry and Molecular Biology (15 credits)
LBUSI4282A The Project Lifecycle
LBIOL4285A Drug Discovery and Development (Including Pharmacology) (15 credits)
LBIOL4286A Human Physiology and Pathophysiology (15 credits)
LBIOL4276A Regulatory Environment in Clinical Trials (30 credits)
Stage 2 (Level 5)
Required Courses
NCHNAP555 IT Project Management (15 credits)
LBIOL52110A Infection and Allergy (Including Applied Microbiology) (15 credits)
LBIOL52102A Oncology (15 credits)
LBIOL52108A Cell and Gene Therapy (15 credits)
LBIOL52109A Industrialisation, Manufacturing and Health Economics (15 credits)
LBIOL52103A Trial Master File and eSystems (15 credits)
LBIOL52104A Biological Samples (15 credits)
LBIOL52105A Statistical Principles Applied to Clinical Trials (15 credits)
Stage 3 (Level 6)
Required Course
End point assessment and project induction
LBIOL62125A Critical Thinking and Ethics (15 credits)
LBIOL62126A Digital Health and Artificial Intelligence (15 credits)
LBIOL62127A Frontier Topics in Bioscience (15 credits)
LISYS62112A Business and Change Management (15 credits)
LBIOL62121AClinical Trials Research Project (60 credits)
Entrance Requirements
Age
The University requires applicants to be at least 18 years old on 1 September in the year of entry.
General Entrance Requirements
The learner will need to be in employment with, or sponsored by, a hiring business, with responsibilities to be aligned to the level 6 Clinical Trials Specialist (ST0609) apprenticeship standards.
Entry requirements are agreed based on numerous factors including availability of additional on-the-job support, by both the employer or sponsor and University As such, entrance requirements may vary. Learners are selected based on their application and an assessment process which is tailored to the learner’s employment/sponsored employment position.
Typically, employers require:
- English and Maths Level 2
- Three A levels (or equivalent at BBB or above) including Biology
- At least Grade 4/C GCSE Maths, English and IT
Some applicants may not have traditional qualifications as listed above, and have prior learning and skills developed from the workplace, these will be considered on a case-by- case basis.
Where a learner will be studying the programme as an apprentice, they will also need to meet the government’s eligibility criteria:
- Have been a UK/EU/ESS resident for the past three years or more prior to starting the programme.
- Have left full-time education prior to the start date of the apprenticeship.
- Be aged at least 16 years old to meet government funding criteria.
Recognition of Prior Learning
Where a student wishes to apply for the recognition of prior learning on the basis of certificated or experiential learning, they should follow the University’s Recognition of Prior Learning Policy.
Learning Outcomes
By completion of the programme:
Knowledge and Understanding
A student will be able to:
K1c | Demonstrate a systematic understanding and detailed knowledge of the underlying scientific principles, theories and concepts of modern bioscience, life science and health, appreciating the uncertainty, ambiguity, and limits of knowledge and how to apply theoretical knowledge to critical thinking. |
K2c | Demonstrate a systematic understanding of how clinical trials have evolved overtime to ensure the safe and effective treatment of participants and how changes in the regulatory landscape, advances in therapeutic approaches, and digitalisation have contributed to this evolution. |
K3c | Demonstrate a systematic understanding and critical knowledge of study design, data management, clinical management systems and stats, to properly assess results and their robustness. |
K4c | Demonstrate a systematic understanding and detailed knowledge of the business environment, ethics, working with stakeholders, managing change, effective communication, project management and understanding how teams work effectively to produce successful project solutions and outcomes. |
Subject Specific Skills
A student will be able to:
S1c | Follow and promote clinical trial management principles and understand the various aspects of trial participant protection such as safety, informed consent, and risk management. |
S2c | Critically evaluate the science that underpins clinical trials using numerical and statistical data analysis, data mining and scholarly reviews and use creative thinking to challenge assumptions and achieve innovative solutions for a range of organisational scenarios. |
S3c | Work autonomously to analyse, interpret data generated as part of the study, communicate ideas, problems and solutions, and comply with business and good clinical practice rules with regard to record keeping, data integrity, reproducibility and confidentiality. |
S4c | Take responsibility for the planning, prioritisation, and timely execution of a range of projects to meet the objectives set by the study plan and business rules. |
Transferable and Employability Skills
A student will be able to:
T1c | Exercise initiative and personal responsibility in professional development and life-long learning, using reflective practice and actively seeking the views of others. |
T2c | Apply analytical, critical-thinking, problem-solving and time-management skills to work creatively, autonomously and effectively to develop innovative and workable solutions to problems in complex and unpredictable contexts. |
T3c | Communicate clear arguments, critical analysis and organisational vision to specialist and non-specialist audiences. |
T4c | Effectively manage diverse stakeholder relationships, change management, work effectively with others and promote inclusivity, diversity, professionalism, integrity and ethics. |
All of the above learning outcomes are mapped to the relevant QAA Subject Benchmark threshold statements and Clinical Trials Specialist Apprenticeship Standard.
Teaching and Learning
Teaching and Learning Activities
The program is delivered through distance blended learning using aVirtual Learning Environment (VLE). This style of delivery combines the benefits of distant and “traditional” or physical place-based learning. The blended-learning work related programme ensures that learners have the opportunity to explore their subject in an incrementally structured, well-managed and appropriate manner. It develops the knowledge, core and subject-specific skills, and transferable skills, required by learners and enhances their confidence. The combination of academic study and work-based learning is a key feature of the programme. Practical and theoretical experiences in the workplace, in tandem with their academic studies, develop and enhance the learner’s specialist knowledge, skills and behaviours.
Assessment
A dedicated Assessment Strategy supports authentic, inclusive, and experiential assessment. This includes offering students a broad range of assessment types, which support active learning. The assessment types available to students are listed in the University Assessment Strategy. Whilst it is not expected that all programmes should offer all of these different assessment types, and choice of assessment should be based on the most effective and appropriate way to test student learning, there will be a range available which empowers students to demonstrate their discipline knowledge via diverse means.
Courses at the University are assessed formatively and summatively in a variety of ways, including:
- Written Assignment (e.g. long-form coursework essay; study report; literature review; reflective essay; dissertation)
- Examination (e.g. open book scheduled exam; closed book; 24-/48-hour exam)
- Presentation (e.g. oral presentation with accompanying slides; Viva voce)
- Role Play (e.g Moot; consultancy simulation)
- Practical ( e.g. lab skills assessments)
- Artefact (e.g. piece of code or poem with an accompanying report)
- Portfolio (students only have one final, formal deadline, but what they submit includes a series of shorter pieces created and reflected upon and revised across the course)
- Set Exercises (e.g a series of short set exercises distributed across the course)
Feedback on formative and summative assessment tasks is provided in verbal or written forms.
Appendix C contains the programme structure and assessment summary.
The University’s Assessment Strategy can be found here.
The University’s Assessment Regulations for Taught Awards can be found here.
Teaching and Learning Environment
The teaching and learning environment includes:
The University’s campus has state-of-the-art teaching rooms and independent and group study spaces.
A Virtual Learning Environment (VLE) for each course with a syllabus and range of additional resources (e.g. readings, question prompts, tasks, assessment briefs, slides or handouts, discussion boards, and sample examination papers and examiners’ reports) to orientate and engage students in their studies.
Northeastern University’s online library digital resources, and other online academic resources, such as JSTOR and the OED. Students are inducted on their use at the start of the programme, and wider digital literacy is reinforced and developed across their studies.
Learners can also apply for a reader’s card to use the British Library membership and apply for membership of any of the City of London libraries. Students at the University can apply for Senate House Library membership.
As part of the wider teaching and learning environment, the University hosts a range of academic and social events in which students, faculty, alumni and interlocutors from outside the academy are brought together.
Research
The University is an active research and knowledge exchange community. Its programmes are designed by faculty with relevant research expertise and teaching is allocated to faculty as far as possible to align with their research expertise and interests.
All learners have the opportunity to develop their research skills as they progress through the programme, culminating with the written assignment in their final year, when their supervisor will be on hand to provide bespoke support.
Learners are invited to a range of faculty research events and, where possible and from time to time.
Student Support and Development
Disabilities and/or Specific Learning Difficulties (SpLDs)
Learners are strongly encouraged to inform the University of any medical conditions, disabilities, specific learning difficulties (SpLD) or neurological differences as soon as is practical. Learners will be asked to submit supporting documentation from a doctor, clinical or educational psychologist detailing the nature of their disability and the impact it is likely to have on their studies in order to help us put in place appropriate support and accommodations. More information can be found in the Student Disability Policy. This data is managed and securely stored by Student Support and Development (SSD). At the start of the academic year, a number of talks and events are held which are designed to support and inform students with regard to mental health, disabilities, safety and learning support.
SSD meet with students as soon as possible, and preferably before the start of the academic year, to discuss their needs and draft a Learning Support Plan (LSP) which outlines the support to be provided both within the University (if appropriate) and externally. If requested by the student, the SDD will then arrange to inform relevant faculty of the student’s needs and any reasonable adjustments required.
If a student is undiagnosed but believes they may have a SpLDS (e.g. Dyslexia) the SDD will help them to access diagnostic services. If the assessment confirms a SpLDS, the SDD will work the student in preparing a LSP and will provide advice about accessing additional funding and support through the Disabled Students Allowance, where a student may be eligible
For more information, please click here.
Quality Assurance and Enhancement
Award Standards
Every programme of study is developed by the faculty, utilising their subject specialists and approved by the University’s Academic Board.
Review and Evaluation Mechanisms
The University has robust procedures, as described in AQF4 Programme and Course Approval and Modifications and AQF5 Annual Monitoring and Reporting, in place to assure the quality of the programme development, delivery, and management, alongside systematic monitoring, ongoing review and enhancement of all University programmes. Enhancements are made as necessary to ensure that systems remain effective and rigorous.
The University utilises constructive feedback from a variety of sources, internal and external, to inform its decision-making process to enhance the programme and the student experience. These feedback sources are:
- Annual Course Reviews, written by the Course Leader, are prepared to enable the Course Leader to reflect on the course, using a variety of data and student/faculty feedback to enhance the course and support the writing of the Annual Programme Review.
- Annual Programme Reviews, written at the end of each academic year, are prepared in order to enhance individual programmes and to plan ahead.
- Annual External Examiner Reports are prepared by the External Examiners, as appointed by the University, to confirm that a programme has been assessed in accordance with the approved documentation and that the student performance meets the appropriate academic standards.
- Formal student feedback mechanisms consist of course questionnaires and Learner Voice Committee meetings at least once each quarter, as well as annual student satisfaction surveys, including external independent surveys, such the National Student Survey.
- Informal student feedback is also valued by the University and this can take the form of students talking or corresponding with faculty or professional staff.
In addition to academic progress monitoring, progression also includes checking that the learner is achieving planned levels of off-the-job learning required by the apprenticeship as set out in the Commitment Statement. This six/eight-weekly discussion between the Success Manager, line manager and learner will also confirm whether the learner is keeping pace with their plan of learning at work, and is meeting the competency progression points as part of their apprenticeship.
Learner attendance at scheduled learning opportunities, as well as monitoring periods of off-the-job training, is monitored through the use of an online Learner Management System.
Version History
Title: BSc (Hons) Applied Biomedical Sciences with Clinical Trials
Approved by: Academic Board Location: Academic handbook/programme specifications and handbooks/undergraduate programme specifications/work related learning |
|||||
Version Number | Date Approved | Date Published | Owner | Proposed Next Review Date | Modification (As per AQF4) & category number |
1.1 | August 2024 | August 2024 | Dr Alistair Robinson | July 2028 | Category 1: Corrections/clarifications to documents which do not change approved content or learning outcomes |
1.0 | July 2024 | July 2024 | Dr Alistair Robinson | July 2028 | |
Version numbering system revised March 2023 | |||||
4.1 | April 2023 | April 2023 | Quality Team | June 2024 | |
Referenced documents | Core Document Development and Management Policy and Procedure; Template for Policies; Template for Procedures; Core Document Development and Management Guidance. | ||||
External Reference Point(s) | None |
Disclaimer
The University has checked the information provided in this Programme Specification and will aim to deliver this programme in keeping with this Programme Specification. However, changes to the programme may sometimes be required arising from annual monitoring, student feedback, and the review and update of courses and programmes. Where this activity leads to significant changes to courses and programmes there will be prior consultation with students and others, wherever possible, and the University will take all reasonable steps to minimise disruption to students. It is also possible that the University may not be able to offer a course or programme for reasons outside of its control, for example, due to the absence of a member of staff or low student registration numbers. Where this is the case, the University will aim to inform applicants and students as soon as possible, and where appropriate, will facilitate the transfer of affected students to another suitable programme.
Copyright
The contents of this Programme Specification are the copyright of the University and all rights are reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, such as electronic, mechanical, photocopied, recorded or otherwise, without the prior consent of the University.
Appendix A – Map to QAA Subject Benchmark
Threshold Standards | Learning Outcome |
Knowledge and Understanding | |
Human anatomy and physiology: the structure, function, neurological and hormonal control of the human body, its component parts and major systems (musculoskeletal, circulatory, respiratory, digestive, renal, urogenital, nervous, endocrine) and their relationship to each other. | K1, S2, T2, T3 |
Cell biology: the structure and function of prokaryotic and eukaryotic cells; the cell as the fundamental unit of life; cell division, cell cycle, stem cells, cell specialisation and cooperation. | K1, S2, T2, T3 |
Biochemistry: key chemical principles relevant to biological systems, the structure and function of biological molecules and the biochemistry of processes which support life, including cellular metabolism and its control. | K1, S2, T2, T3 |
Microbiology: the structure, physiology, biochemistry, identification, classification, and control of microorganisms, including the roles of normal flora. | K1, S2, T2, T3 |
Immunology: acute and chronic inflammation, structure, function and mechanisms of action of the components of the immune system; innate and acquired immunity. | K1, S2, T2, T3 |
Developmental biology, which may include topics such as embryonic development, human life cycles, ageing, stem cells and regenerative medicine. | K1, S2, T2, T3 |
Physics and chemistry sufficient to support understanding of biochemical and biophysical processes and instrumentation. | K1, S2, T2, T3 |
Genetics, genomics and human variation: the structure and function of genes, the principles of their inheritance, genetic disorders with particular biomedical significance, evolution and population biology. | K1, S2, T2, T3 |
Molecular biology: the structure and function of biologically important molecules, including DNA, RNA and proteins and the molecular events that govern cell function; molecular biology overlaps with biochemistry, genetics and cell biology. | K1, S2, T2-T3 |
The causes and pathology of common diseases and the impact of lifestyle upon human health. | K1, S2, T2-T3 |
Bioinformatics and systems biology: the analysis of high volumes of biological data, including use of appropriate computational tools and algorithms; appreciation and modelling of the properties of a network of interacting components in a system, as well as the properties of the components themselves. | K1-K3, S2, S3, T2, T3 |
Pharmacology: the importance of drug actions in the living organism for prevention and treatment of disease; the principles of drug-receptor interactions and the relationship between dose and response, routes of administration, types of drugs, how drugs are metabolised and eliminated from the body, toxic effects; approaches for drug discovery; personalised medicine/precision medical science. | K1, K2, S2, T2-T3 |
Approaches | |
Interdisciplinary and, where appropriate, multidisciplinary approach in advancing knowledge and understanding of the processes and mechanisms of life, from the molecular and cellular levels through to the whole body and the environment in which a person lives. | K1, K2, S2, T2 |
Engagement with the essential facts, major concepts, principles and theories associated with the chosen subject. | K1-K4, T1-T3 |
Competence in the basic experimental and/or technical skills appropriate to the subject under study; relevant knowledge and understanding of a range of methodologies for data analysis, including the application of appropriate statistical methods and other analytical tools. | K3, S3, T2, T3 |
Understanding of information from a variety of sources such as texts, published journal articles, reports and clinical data within the context of biomedical sciences; familiarity with methods of acquiring, interpreting and analysing information with a critical understanding of its use and limitations. | K3, S2, S3, T2, T3 |
Familiarity with relevant terminology and classification systems. | K1-K4 |
Awareness of the contribution of the subject area to the development of knowledge about the complexity of human health and disease. | S1, T2 |
Competence in the use of a range of appropriate communication platforms, both digital and physical, for the effective dissemination of information to scientific and lay audiences. | S2, S3, T3, T4 |
Engagement with current developments in the subject area and awareness of their contribution to debate and controversies; their applications to the quality and sustainability of health and well-being; the philosophical and ethical issues involved and awareness of intellectual property (IP) and how scientific advances can be secured and progressed by the application of intellectual property rights (IPRs). | K2, K4, S1, S3, |
Appreciation and enactment of the applicability of the subject-specific and transferable skills and knowledge of graduates to a wide variety of career paths and further study opportunities both within and beyond the life sciences. | T1, T4 |
Attributes | |
An appreciation of the complexity and diversity of human processes in health and disease. | S1-S4 |
The ability to read and evaluate appropriate literature with a full and critical understanding, including the context, aims, objectives, experimental design, methodology, data interpretation and application of the study. | S2, S3, T2, T3 |
The capacity to give a clear, current and accurate account of their subject area, the ability to critically discuss and debate both with specialists and non-specialists, using appropriate scientific language. | T3 |
The ability to successfully apply a variety of methods of study in investigating, recording and analysing material. | S1-S3 |
The ability to think independently, work autonomously and solve problems. | S2-S4, T2 |
An understanding of how to identify, protect and exploit intellectual property (IP) as part of the scientific innovation process. | |
An appreciation of the global reach of the subject area, the impact on human life and the environment and the ethical considerations implicit in their application. | S4, T4 |
* This is intended to mean that all students (taken over all years) graduating with an honours degree in this discipline will have achieved this.
QAA benchmark statement can be found here.
Appendix B – Map of Courses to Learning Outcomes
Knowledge and Understanding | K1a | K1b | K1c | K2a | K2b | K2c | K3a | K3b | K3c | K4a | K4b | K4c |
FHEQ Level 4 | ||||||||||||
LBIOL4274A Introduction To Clinical Trials | X | X | ||||||||||
LBIOL4283A Applied Cell Biology | X | |||||||||||
LBIOL4284A Biochemistry And Molecular Biology | X | |||||||||||
LBUSI4282A The Project Lifecycle | X | |||||||||||
LBIOL4285A Drug Discovery And Development (Including Pharmacology) | X | |||||||||||
LBIOL4286A Human Physiology and Pathophysiology | X | X | ||||||||||
LBIOL4276A Regulatory Environment in Clinical Trials | X | X | ||||||||||
FHEQ Level 5 | ||||||||||||
NCHNAP555 IT Project Management | X | |||||||||||
LBIOL52110A Infection And Allergy (Including Applied Microbiology) | X | |||||||||||
LBIOL52102A Oncology | X | X | ||||||||||
LBIOL52108A Cell And Gene Therapy | X | X | X | |||||||||
LBIOL52109A Industrialisation, Manufacturing And Health Economics | X | X | ||||||||||
LBIOL52103A Trial Master File And E-Systems | X | X | X | |||||||||
LBIOL52104A Biological Samples | X | X | X | |||||||||
LBIOL52105A Statistical Principles applied to Clinical Trials | X | X | X | |||||||||
FHEQ Level 6 | ||||||||||||
LBIOL62125A Critical Thinking and Ethics | X | X | X | |||||||||
LBIOL62126A Digital Health and Artificial Intelligence | X | X | X | |||||||||
LBIOL62127A Frontier Topics in Bioscience | X | X | X | |||||||||
LISY62112A Business and Change Management | X | X | ||||||||||
LBIOL62121A Clinical Trials Research Project | X | X | X | X |
Subject Specific Skills | S1a | S1b | S1c | S2a | S2b | S2c | S3a | S3b | S3c | S4a | S4b | S4c |
FHEQ Level 4 | ||||||||||||
LBIOL4274A Introduction To Clinical Trials | X | X | ||||||||||
LBIOL4283A Applied Cell Biology | X | X | ||||||||||
LBIOL4284A Biochemistry And Molecular Biology | X | X | ||||||||||
LBUSI4282A The Project Lifecycle | X | X | ||||||||||
LBIOL4285A Drug Discovery And Development (Including Pharmacology) | X | X | ||||||||||
LBIOL4286A Human Physiology and Pathophysiology | X | X | ||||||||||
LBIOL4276A Regulatory Environment in Clinical Trials | X | X | X | |||||||||
FHEQ Level 5 | ||||||||||||
NCHNAP555 IT Project Management | X | X | ||||||||||
LBIOL52110A Infection And Allergy (Including Applied Microbiology) | X | X | ||||||||||
LBIOL52102A Oncology | X | X | ||||||||||
LBIOL52108A Cell And Gene Therapy | X | X | ||||||||||
LBIOL52109A Industrialisation, Manufacturing And Health Economics | X | X | ||||||||||
LBIOL52103A Trial Master File And E-Systems | X | X | X | |||||||||
LBIOL52104A Biological Samples | X | X | ||||||||||
LBIOL52105A Statistical Principles applied to Clinical Trials | X | X | ||||||||||
FHEQ Level 6 | ||||||||||||
LBIOL62125A Critical Thinking and Ethics | X | |||||||||||
LBIOL62126A Digital Health and Artificial Intelligence | X | X | X | |||||||||
LBIOL62127A Frontier Topics in Bioscience | X | X | ||||||||||
LISY62112A Business and Change Management | X | X | ||||||||||
LBIOL62121A Clinical Trials Research Project | X | X | X | X |
Transferable Skills | T1a | T1b | T1c | T2a | T2b | T2c | T3a | T3b | T3c | T4a | T4b | T4c |
FHEQ Level 4 | ||||||||||||
LBIOL4274A Introduction To Clinical Trials | X | X | X | |||||||||
LBIOL4283A Applied Cell Biology | X | X | ||||||||||
LBIOL4284A Biochemistry And Molecular Biology | X | X | ||||||||||
LBUSI4282A The Project Lifecycle | X | X | X | X | ||||||||
LBIOL4285A Drug Discovery And Development (Including Pharmacology) | X | X | ||||||||||
LBIOL4286A Human Physiology and Pathophysiology | X | X | ||||||||||
LBIOL4276A Regulatory Environment in Clinical Trials | X | X | X | |||||||||
FHEQ Level 5 | ||||||||||||
NCHNAP555 IT Project Management | X | X | X | X | ||||||||
LBIOL52110A Infection And Allergy (Including Applied Microbiology) | X | X | ||||||||||
LBIOL52102A Oncology | X | X | X | |||||||||
LBIOL52108A Cell And Gene Therapy | X | X | ||||||||||
LBIOL52109A Industrialisation, Manufacturing And Health Economics | X | X | ||||||||||
LBIOL52103A Trial Master File And E-Systems | X | X | X | X | ||||||||
LBIOL52104A Biological Samples | X | X | X | |||||||||
LBIOL52105A Statistical Principles applied to Clinical Trials | X | X | X | X | ||||||||
FHEQ Level 6 | ||||||||||||
LBIOL62125A Critical Thinking and Ethics | X | X | X | X | ||||||||
LBIOL62126A Digital Health and Artificial Intelligence | X | X | ||||||||||
LBIOL62127A Frontier Topics in Bioscience | X | X | ||||||||||
LISY62112A Business and Change Management | X | X | X | X | ||||||||
LBIOL62121A Clinical Trials Research Project | X | X | X | X |
Appendix C – Map to Apprenticeship Standard
ICT | ACB | TPL | BMB | HPP | RECT
|
ITPM | IA | O | CGT | IMHE | TMF ES | BS | SPACT | CTE | DHAI | FTB | BCM | CTRP | |
Knowledge | |||||||||||||||||||
1 | x | x | x | x | |||||||||||||||
2 | x | x | x | x | x | ||||||||||||||
3 | x | x | x | ||||||||||||||||
4 | x | ||||||||||||||||||
5 | x | x | x | ||||||||||||||||
6 | x | x | |||||||||||||||||
7 | x | x | x | x | x | x | x | x | |||||||||||
8 | x | x | x | x | x | x | |||||||||||||
Skills | |||||||||||||||||||
1 | x | ||||||||||||||||||
2 | x | ||||||||||||||||||
3 | x | x | x | ||||||||||||||||
4 | x | x | x | ||||||||||||||||
5 | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
6 | x | x | x | x | |||||||||||||||
Behaviours | |||||||||||||||||||
1 | x | x | x | x | x | ||||||||||||||
2 | x | x | |||||||||||||||||
3 | x | x | x | ||||||||||||||||
4 | x | x | x | x | x | x | x | ||||||||||||
5 | x | x | x | x | x | x | x | ||||||||||||
6 | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
Appendix D – Programme Structure and Summative Assessment Summary
Code | Course Title | Credit
|
Type | Mode | Assessment Weighting % & Activity Type
(code overleaf) |
|||||
AE1 | Activity
type
|
AE2 | Activity type | AE3 | Activity type | |||||
Level 4 | ||||||||||
LBIOL4274A | Introduction To Clinical Trials | 15 | C | DL/WB | 50% | WA | 50% | Set | ||
LBIOL4283A | Applied Cell Biology | 15 | C | DL/WB | 50% | P | 50% | Set | ||
LBIOL4284A | Biochemistry And Molecular Biology | 15 | C | DL/WB | 40% | Exam | 60% | P | ||
LBUSI4282A | The Project Lifecycle | 15 | C | DL/WB | 50% | Set | 50% | WA | ||
LBIOL4285A | Drug Discovery And Development (Including Pharmacology) | 15 | C | DL/WB | 50% | WA | 50% | Set | ||
LBIOL4286A | Human Physiology and Pathophysiology | 15 | C | DL/WB | 40% | Exam | 60% | Set | ||
LBIOL4276A | Regulatory Environment in Clinical Trials | 30 | C | BK/BL | 30% | Pres | 70% | P | ||
Level 5 | ||||||||||
NCHNAP555 | IT Project Management | 15 | C | DL/WB | 70% | WA | 30% | Exam | ||
LBIOL52110A | Infection And Allergy (Including Applied Microbiology) | 15 | C | DL/WB | 40% | Exam | 60% | P | ||
LBIOL52102A | Oncology | 15 | C | DL/WB | 30% | Exam | 70% | WA | ||
LBIOL52108A | Cell And Gene Therapy | 15 | C | DL/WB | 50% | P | 50% | Set | ||
LBIOL52109A | Industrialisation, Manufacturing And Health Economics | 15 | C | DL/WB | 40% | Exam | 60% | Set | ||
LBIOL52103A | Trial Master File And E-Systems | 15 | C | DL/WB | 50% | WA | 50% | P | ||
LBIOL52104A | Biological Samples | 15 | C | DL/WB | 30% | Exam | 70% | WA | ||
LBIOL52105A | Statistical Principles applied to Clinical Trials | 15 | C | DL/WB | 30% | Pract | 70% | Set | ||
Level 6 | ||||||||||
LBIOL62125A | Critical Thinking and Ethics | 15 | C | DL/WB | 50% | WA | 50% | Set | ||
LBIOL62126A | Digital Health and Artificial Intelligence | 15 | C | DL/WB | 50% | Set | 50% | WA | ||
LBIOL62127A | Frontier Topics in Bioscience | 15 | C | DL/WB | 50% | P | 50% | WA | ||
LISY62112A | Business and Change Management | 15 | C | DL/WB | 70% | Report | 30% | WA | ||
LBIOL62121A | Clinical Trials Research Project | 60 | C | DL/WB | 15% | WA | 60% | WA | 25% | Pres |
Course Type:
R = Required or O = Optional
Course Mode:
CD = Campus Delivery; BK = Block Delivery; DL = Distance Learning and Self-Directed Learning; OL = Online Learning; WB = Work Based Learning
Assessment Weighting:
AE1 = Assessment Element 1; AE2 = Assessment Element 2; AE3 = Assessment Element 3
Assessment Activity Type Code
Written assignment WA
Examination Exam
Presentation Pres
Role play RP
Portfolio P
Set exercise Set
Practical Pract
Artefact Arte
Appendix E – Exit Awards
Certificate in Higher Education
In order for a student to be awarded a Certificate in Higher Education (Cert HE), they are required to have achieved 120 credits at the University in any combination across Level 4 and Level 5.
Learning Outcomes
By completion of the programme:
Knowledge and Understanding
A student will be able to:
K1a | Demonstrate a basic understanding and knowledge of the main underlying scientific principles, theories and concepts of modern bioscience, life science and health. |
K2a | Demonstrate a basic understanding of how clinical trials have evolved overtime to ensure the safe and effective treatment of participants and how changes in the field have contributed to this evolution. |
K3a | Demonstrate a basic understanding and knowledge of study design, data management, clinical management systems and stats, to properly assess results and their robustness. |
K4a | Demonstrate a basic understanding and knowledge of the business environment, ethics, effective communication, project management and understanding how teams work effectively to produce successful project solutions and outcomes. |
Subject Specific Skills
A student will be able to:
S1a | Follow and promote clinical trial management principles and understand the various aspects of trial participant protection such as safety, informed consent, and risk management. |
S2a | Evaluate the science that underpins clinical trials and propose solutions for select organisational scenarios. |
S3a | Communicate ideas, problems and solutions coherently, and comply with business and good clinical practice rules with regard to record keeping, data integrity, reproducibility and confidentiality. |
Transferable and Employability Skills
A student will be able to:
T1a | Exercise personal responsibility in professional development and life-long learning. |
T2a | Apply problem-solving and time-management skills to develop workable solutions to select problems. |
T3a | Communicate clear arguments. |
T4a | Work effectively with others and promote inclusivity, diversity, professionalism, integrity and ethics. |
Diploma in Higher Education
In order for a student to be awarded a Diploma in Higher Education (Dip HE), they are required to have achieved 240 credits in any combination across Level 4, Level 5 and Level 6, with a minimum of 120 credits at the University.
Learning Outcomes
By completion of the programme:
Knowledge and Understanding
A student will be able to:
K1b | Demonstrate a basic understanding and knowledge of the main underlying scientific principles, theories and concepts of modern bioscience, life science and health. |
K2b | Demonstrate a basic understanding of how clinical trials have evolved overtime to ensure the safe and effective treatment of participants and how changes in the field have contributed to this evolution. |
K3b | Demonstrate a basic understanding and knowledge of study design, data management, clinical management systems and stats, to properly assess results and their robustness. |
K4b | Demonstrate a basic understanding and knowledge of the business environment, ethics, effective communication, project management and understanding how teams work effectively to produce successful project solutions and outcomes. |
Subject Specific Skills
A student will be able to:
S1a | Follow and promote clinical trial management principles and understand the various aspects of trial participant protection such as safety, informed consent, and risk management. |
S2a | Evaluate the science that underpins clinical trials and propose solutions for select organisational scenarios. |
S3a | Communicate ideas, problems and solutions coherently, and comply with business and good clinical practice rules with regard to record keeping, data integrity, reproducibility and confidentiality. |
Transferable and Employability Skills
A student will be able to:
T1a | Exercise personal responsibility in professional development and life-long learning. |
T2a | Apply problem-solving and time-management skills to develop workable solutions to select problems. |
T3a | Communicate clear arguments. |